Zymeworks Inc.
ZYMENasdaqCIK 1937653HealthcareFiscal year ends Dec 31
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2616:11 ET | DEF 14A | Proxy statementPeriod 2026-12-15 | 0001193125-26-431936 |
| 2026-10-2306:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000055 |
| 2026-09-2316:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-399383 |
| 2026-08-2510:54 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001937653-26-000051 |
| 2026-08-0616:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001937653-26-000047 |
| 2026-08-0616:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000046 |
| 2026-06-2907:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-286829 |
| 2026-05-1416:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-224161 |
| 2026-05-0716:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001937653-26-000034 |
| 2026-05-0716:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000033 |
| 2026-04-0106:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-135610 |
| 2026-03-0206:28 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-084082 |
| 2026-03-0206:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001937653-26-000015 |
| 2026-03-0206:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-26-000013 |
| 2026-01-1216:34 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010480 |
| 2025-12-3017:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-337268 |
| 2025-11-1917:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000711 |
| 2025-11-1806:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-285259 |
| 2025-11-1706:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-283873 |
| 2025-11-1016:24 ET | DEF 14A | Proxy statementPeriod 2025-12-30 | 0001193125-25-274338 |
| 2025-11-0616:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001937653-25-000077 |
| 2025-11-0616:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000076 |
| 2025-09-0206:58 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-193351 |
| 2025-08-1108:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-177505 |
| 2025-08-0716:20 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001937653-25-000049 |
| 2025-08-0716:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000047 |
| 2025-06-2718:14 ET | SCHEDULE 13D | Ownership report, active investor | 0000935836-25-000439 |
| 2025-06-2716:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-151279 |
| 2025-05-3017:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132299 |
| 2025-05-0816:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001937653-25-000027 |
| 2025-05-0816:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000026 |
| 2025-04-0816:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000268 |
| 2025-03-1719:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000230 |
| 2025-03-0516:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001937653-25-000014 |
| 2025-03-0516:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-25-000012 |
| 2025-02-1818:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000186 |
| 2025-02-1806:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028050 |
| 2025-01-1319:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000060 |
| 2025-01-0816:16 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-003519 |
| 2024-12-2319:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-24-000776 |
| 2024-12-1116:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-24-275534 |
| 2024-11-2116:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-263398 |
| 2024-10-3116:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001937653-24-000050 |
| 2024-10-3116:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001937653-24-000049 |
| 2024-10-2916:06 ET | DEF 14A | Proxy statementPeriod 2024-12-10 | 0001193125-24-246527 |
| 2024-10-1816:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-24-239630 |
| 2024-09-0316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-212062 |
| 2024-08-0207:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-192058 |
| 2024-08-0116:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-191535 |
| 2024-08-0116:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001937653-24-000041 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:15 ET. Listed shows no prices and gives no investment advice.